Enjoy FREE shipping on your first order! (Minimum $99 purchase)
A degenerative neurological condition is Parkinson’s disease (PD), which mostly affects movement. The management of the disease's symptoms gets more difficult as it progresses. Many individuals have "off" episodes, or times when the effects of the medicine wear off and symptoms reappear, even if levodopa is still a mainstay of treatment. Xadago, also known as safinamide, can help with that.
For those with erratic symptoms, Xadago, which was approved by the FDA in 2017, appears as an adjuvant medication to levodopa/carbidopa.
Let us learn more about it.
Safinamide is a once-daily oral drug used as an adjuvant treatment for Parkinson's disease under the brand name Xadago. It is a member of a class of medications known as monoamine oxidase B (MAO-B) inhibitors, which function by preventing the brain's enzyme from breaking down dopamine. Dopamine levels become more stable as a result, and motor symptoms are better managed.
However, safinamide has a special dual mode of action because it not only inhibits MAO-B but also modifies glutamate, a neurotransmitter implicated in Parkinson's disease symptoms.
A reversible and specific inhibitor of monoamine oxidase B (MAO-B) is safinamide. In the brain, dopamine is broken down by the enzyme MAO-B. Blocking MAO-B helps to aid a longer duration of dopamine activity, improved motor symptoms, such as stiffness, slowness, and tremor, and reduced "off" times translates into fewer fluctuations throughout the day.
It's another mechanism that includes glutamate, which is an excitatory neurotransmitter that is likewise regulated by safinamide and is involved in Unusual nerve signals, the involuntary motions known as dyskinesia, and the degeneration of neurons.
Glutamate modulation may help Xadago lessen excessive brain cell activation, which can lead to both motor and non-motor symptoms.
Adults suffering from Parkinson's disease can benefit from Xadago.
Once taken orally once a day, Xadago is commonly used in combination with levodopa/carbidopa to assist in reducing motor symptoms and smooth out "off" periods.
The usual Xadago dosage schedule is as follows:
While not everyone will have side effects, Xadago (safinamide) can have them, like any other prescription. While the majority of side effects are low to moderate, some can be more severe and necessitate medical care.
When taking Xadago, the following adverse effects are most commonly reported:
Some adverse effects, though less frequent, could be more dangerous:
While it can be a highly effective treatment for Parkinson’s, Xadago must be used with caution with other medications. Some of the drug interactions include:
Some of the precautions and Contraindications for Xadago include:
No, Parkinson's disease cannot be cured by Xadago. Although it doesn't prevent or reverse Parkinson's disease, it helps control symptoms, particularly "off" episodes, by enhancing the effectiveness of other Parkinson's drugs.
Usually, Xadago gets to work in a few days to a few weeks.
Although it may take two to four weeks to fully experience the benefits, some patients may experience improvements in their "off" time and motor symptoms as early as the first week.
Indeed, Xadago is made especially to be taken alongside levodopa.
When the effects of levodopa wear off, it is used as an adjuvant medication to help manage "off" episodes. By intensifying and prolonging the effects of levodopa, Xadago improves symptom control over the course of the day.
Unless your next dose is practically due, take Xadago as soon as you remember if you miss one. Avoid taking two doses to compensate for missing one. Continue with your usual dosing plan and omit the missed dose if it's almost time for your next one.
Yes, some people may experience hallucinations and sleep issues after using Xadago. Insomnia, severe daytime drowsiness, or even unexpected sleep attacks are possible for certain individuals.
Particularly in elderly persons or those with a history of mental illnesses, Xadago may result in hallucinations or disorientation.
Indeed, the FDA has approved a generic form of Xadago (safinamide). It might not be commercially available just yet, though, because of things like market exclusivity and patent protections. Currently, the most common form of Xadago is a brand-name drug.
Protein may hinder the absorption of levodopa, reducing its effectiveness. Spread out your protein consumption throughout the day, and think about taking levodopa 30 to 60 minutes before meals. Foods that contain tyramine, which might increase blood pressure when combined with MAO-B inhibitors like Xadago. Processed and sugary foods can exacerbate digestive problems like constipation. Alcohol may make balance problems worse, interfere with prescription drugs, or make you drowsier. Constipation is a common symptom of Parkinson's, so one should avoid diets low in fiber.
> Genvoya Cost in the USA: Savings and Coverage
> Summer Migraine Management: Triggers & Relief
> Starting Genvoya: What to Expect and How It Treats HIV-1